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SUMMARY 
The International League Against Epilepsy (ILAE) Diagnostic Methods Commission charged 
the Neuropsychology Task Force with the job of developing a set of recommendations to 
address the following questions: (i) What is the role of a neuropsychological assessment? (ii) 
Who should do a neuropsychological assessment? (iii) When should people with epilepsy be 
referred for a neuropsychological assessment? and (iv) What should be expected from a 
neuropsychological assessment? The recommendations have been broadly written for health 
care clinicians in established epilepsy settings as well as those setting up new services. They 
are based on a detailed survey of neuropsychological assessment practices across international 
epilepsy centres, and a formal ranking of specific recommendations for advancing clinical 
epilepsy care generated by specialist epilepsy neuropsychologists from around the world. 
They also incorporate the latest research findings to establish minimum standards for training 
and practice, reflecting the many roles of neuropsychological assessment in the routine care of 
children and adults with epilepsy. The recommendations endorse routine screening of 
cognition, mood and behaviour in new onset epilepsy, and describe the range of situations 
when more detailed, formal neuropsychological assessment is indicated. They identify a core 
set of cognitive and psychological domains that should be assessed to provide an objective 
account of an individual’s cognitive, emotional and psychosocial functioning, including 
factors likely contributing to deficits identified on qualitative and quantitative examination. 
The recommendations also endorse routine provision of feedback to patients, families and 
clinicians about the implications of the assessment results, including specific clinical 
recommendations of what can be done to improve a patient’s cognitive or psychosocial 
functioning and alleviate the distress of any difficulties identified. By canvassing the breadth 
and depth of scope of neuropsychological assessment, this report demonstrates the pivotal 
role played by this noninvasive and minimally resource intensive investigation in the care of 
people with epilepsy. 
KEY WORDS: neuropsychology, assessment, training, minimum standards, adult, paediatric 
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The role of neuropsychology in the assessment and treatment of people with epilepsy is 
constantly evolving in response to new classifications of the disorder, rapid advances in 
neuroimaging and genetic techniques, the development of new treatments, and improved 
understanding of the nature, timing and causes of cognitive problems. At a meeting held in 
Washington DC in December 2013, members of the ILAE Diagnostic Methods Commission 
asked the Neuropsychology Task Force to create and disseminate recommendations to answer 
the following questions: 
i. What is the role of a neuropsychological assessment? 
ii. Who should do a neuropsychological assessment? 
iii. When should people with epilepsy be referred for a neuropsychological assessment? 
iv. What should be expected from a neuropsychological assessment? 
The following recommendations have been written to be broad enough to assist health care 
clinicians in established epilepsy centres and community settings, as well as those who are 
involved in setting up new services. It is explicitly recognized that these recommendations 
may be difficult (if not impossible) to implement in certain low- and middle-income settings 
where specialist training is not available and there are large treatment gaps for basic health 
care interventions. In these settings, these recommendations should be viewed as aspirational 
and a resource for lobbying local health organizations to expand training and access for 
neuropsychological services. 
Methods 
The recommendations build on the work of the former ILAE Neuropsychology Task Force 
(2009-2013) that comprehensively examined models of neuropsychological care in people 
with epilepsy, and undertook a formal process of ranking a large set of specific 
recommendations for advancing clinical care in epilepsy generated by more than 50 epilepsy 
specialists from 13 countries with expertise relevant to adult and paediatric neuropsychology.1 
In addition, a detailed survey of neuropsychological assessment practices in epilepsy was 
conducted across 17 countries to identify common practices in the field.2 The results endorsed 
assessment of a core set of cognitive and psychological domains in people with epilepsy that 
are directly reflected in the current recommendations.2,3 The recommendations are also 
informed by the latest research findings, and the outcome of detailed discussions between 
specialist epilepsy neuropsychologists from around the world serving on the current ILAE 
Neuropsychology Task Force (2013-2017), with the aim of providing a representative, 
consensus view. 
The recommendations are broadly focused on the role of neuropsychological assessment in 
the routine care of children and adults with epilepsy across a diversity of health care settings. 
The long-standing role that neuropsychology has played in the diagnostic work-up of patients 
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admitted for surgical characterisation and associated specialized topics4 will be addressed in 
the second report in this series. 
WHAT IS THE ROLE OF A NEUROPSYCHOLOGICAL ASSESSMENT? 
The role of a neuropsychological assessment in the routine care of people with epilepsy is 
to provide a comprehensive and objective assessment of an individual’s cognitive and 
psychological functioning. This is typically for the purpose of addressing a referral question, 
taking account of the patient’s medical history and broader psychosocial functioning. At times 
this role may be diagnostic, given that impairments in cognition or behaviour can provide 
clues to the lateralisation or localisation of the seizure network, or the nature of the epilepsy 
syndrome. It may also involve differentiating the neurological, psychological and social 
processes impacting upon a patient’s clinical presentation at a given point in time, to inform 
clinical decision-making and the provision of optimal treatment. At other times the role may 
be prognostic, with assessments used to monitor and estimate the impact of ongoing seizures 
or a particular treatment on the future cognitive and behavioural functioning of an individual. 
Moreover, the role typically involves psychoeducation of patients and families about the 
nature and implications of the assessment results, addressing the impact of epilepsy on the 
patient and family, management of cognitive or behavioural co-morbidities, and any 
educational, vocational or psychosocial difficulties. It may also extend to the provision of 
psychological, cognitive or behavioural treatments to assist patients with cognitive and 
psychosocial functioning in day-to-day life. 
Given these many and varied roles, it goes without saying that neuropsychological 
assessment in epilepsy involves more than just the administration, scoring and interpretation 
of tests. It requires the training and background to synthesize information from the tests, 
combined with a carefully-taken biopsychosocial history, other neurodiagnostic test results, 
and behavioural observations to communicate the results and their implications effectively to 
patients, families and clinicians. Needless to say, this cannot be achieved just through the use 
of screening or computerized assessment batteries, or evaluations based primarily on patient 
self-report. While these procedures provide useful ways of identifying individuals who may 
require more detailed neuropsychological assessment, they should be considered adjunct 
procedures rather than a substitute for neuropsychological assessment. At the core of 
neuropsychological assessment in people with epilepsy is an understanding that epilepsy 
arises from a disease of brain networks that support normal developmental and aging 
processes through complex and dynamically changing cognitive and behavioural functions,5 
the assessment of which lies at the interface of mind, brain and behaviour. 
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WHO SHOULD DO A NEUROPSYCHOLOGICAL ASSESSMENT? 
Trained personnel 
Neuropsychological assessments should only be conducted by individuals who have 
undergone specialist training in clinical neuropsychology. This may involve the assistance of 
a psychometrician working under the supervision of a clinical neuropsychologist. In some 
parts of the world training is in addition to basic training as a clinical psychologist, whereas in 
other regions, neuropsychologists train separately. Neuropsychological training requires 
detailed knowledge of brain-cognition-behaviour relationships, based on rigorous training in 
brain anatomy and function as well as cognitive processes of the human mind and their 
disorders. It also requires a comprehensive understanding of the psychometric properties of 
standardised cognitive and behavioural assessments, their skilled delivery and clinical 
interpretation. This specialist training, combined with the experience of working with general 
neurological or psychiatric populations, forms the bedrock of core competencies within the 
profession. Additional epilepsy-specific training is then required to develop expertise in 
assessing the relative contributions of neurological, cognitive, psychosocial, and cultural 
factors to the neuropsychological profiles of people with epilepsy6 (Figure 1). In some, but 
not all parts of the world, epilepsy-specific training is associated with formal credentials and 
boarding procedures. Furthermore, for those working with children, training in developmental 
psychology and developmental neuropsychology is essential, because brain-behaviour 
relationships differ between adults and children. 
(Insert Figure 1 about here) 
WHEN SHOULD PEOPLE WITH EPILEPSY BE REFERRED FOR AN ASSESSMENT? 
At epilepsy onset for routine screening of cognitive or behavioural difficulties 
In children and adults, cognitive or behavioural difficulties may already be present at 
seizure onset, with a clinical history of problems or complaints preceding diagnosis. Research 
has clearly shown that approximately half of newly diagnosed children or adults with epilepsy 
have demonstrable cognitive or behavioural difficulties on testing.7-9  Thus, we recommend at 
a minimum routine screening for cognitive and behavioural difficulties in all children and 
adults newly diagnosed with epilepsy, accompanied by the provision of advice on the risks of 
cognitive and behavioural difficulties associated with the condition. As noted above, routine 
screening provides an efficient and relatively inexpensive method for identifying people who 
require a more detailed (and expensive) neuropsychological assessment. Given the insidious 
evolution of some epilepsies, it can also provide a minimal baseline from which to measure 
the cognitive course of the disease, or the effects of subsequent treatment. In addition to 
computerized assessment batteries or self-report questionnaires, screening may involve 
clinician questioning of the patient’s subjective cognitive complaints, such as attention, 
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memory or word finding difficulties. Psychological adjustment problems or mood disorder 
may also be present at diagnosis, for which the patient and family may benefit from 
psychoeducation or psychological treatment.10 The benefits of brief or targeted interventions 
at onset may extend to longer-term medical outcomes, as mood and adjustment difficulties at 
the time of diagnosis have been shown to predict seizure recurrence.11 
When there are signs or symptoms of a focal cognitive impairment 
When cognitive deficits are suspected, a neuropsychological assessment provides an 
objective measure of the extent to which these deficits are global or more focal and limited to 
particular domains. The primary purpose of the assessment can be to gauge a person’s current 
cognitive functioning without consideration of aetiological factors. Alternatively, focal 
symptoms or signs of memory difficulties or other cognitive problems can be used to provide 
critical diagnostic information about the syndrome, lesion location, or seizure network 
underpinning the patient’s epilepsy. The assessment may also be used to identify the presence 
of atypical cognitive organisation for particular functions (i.e., reversed language dominance), 
or to differentiate ictal from inter-ictal cognitive and behavioural effects. 
In adults with well-controlled epilepsy, memory difficulties are often the only daily 
manifestation of their condition, and their subjective complaints may be frequent. These 
complaints may reflect psychological (depression or anxiety) or neurocognitive mechanisms 
depending on the location of the epileptogenic focus. Neuropsychological assessment may 
help differentiate between these two explanations and inform treatment decisions.12 
Moreover, while subjective memory difficulties may be the presenting complaint, oftentimes 
the fundamental cognitive problem may lie in other areas. For example, word finding 
difficulties may give rise to a subjective memory complaint that indicates pathology in the 
language network rather than the memory system per se. 
In the absence of patient subjective complaints, family reports of difficulties with 
particular functions like memory, attention or disorganisation in daily life may trigger the 
need for an assessment, particularly in people with frontal lobe dysfunction who lack insight 
into their difficulties. Screening or formal assessment may also be indicated in patients with 
epilepsies that have been traditionally considered cognitively ‘benign’, such as the genetic 
generalized epilepsies and other syndromes.13-15 Alternatively, memory or other cognitive 
difficulties may become apparent upon assessment, providing an independent and objective 
basis for educating the patient and others about the neurologic basis of the problem and 
justifying a referral for intervention. Early referral and intervention is particularly pertinent in 
cases where difficulties may be reversible. 
In children, attention and memory difficulties may be reported by family members and/or 
school staff and may also be apparent on clinical examination. Memory deficits are more 
likely to be apparent in adolescents than in younger children.16,17 Even in children with focal 
epilepsy, cognitive impairments may be diffuse and affect multiple domains, with similarities 
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in impairments noted between many epilepsy syndromes.18 Thus, it is important to ask about 
cognitive deficits, and not rely on the idea of syndrome-specific disorders. Because of 
developmental changes, the child’s pattern of cognitive strengths and weaknesses may also 
change over time. Likewise, as the complexity of academic demands increases in higher grade 
levels, children who did well in school in earlier years may begin to struggle. For these 
reasons, repeat assessments over time may be warranted to provide the necessary supports for 
children and their families. 
When there is a question of neurodevelopmental delay, behavioural or learning 
difficulties, or cognitive decline 
In children with epilepsy, developmental delay may be obvious. In this case, longitudinal 
neuropsychological assessments can be used to quantify and track a child’s progress across 
multiple domains (cognitive, behavioural, emotional, social) and ensure that appropriate 
educational, family and social supports are in place. In others with apparently normal 
development, problems at home or recent onset of learning difficulties at school may point to 
underlying cognitive decline, with a slowed rate of cognitive development and gradual falling 
behind, or a premature plateau in development.17,19 Here again, neuropsychological 
assessment can be used to characterise and quantify any difficulties and monitor development 
over time so that available treatments or supports may be implemented. 
In adults, problems with work, memory, or adaptive skills may have an insidious onset, 
only gradually coming to the attention of the patient or family. Although the rate of normal 
age-related decline in cognitive function is similar in people with epilepsy to that in the 
healthy population, many start from a lower base and so develop disabling cognitive or 
behavioural problems earlier in life.17 Repeated head injuries, episodes of status, and atypical 
seizure clusters may also precipitate or exacerbate cognitive decline.20-22 In these cases, serial 
neuropsychological assessments again ensure any decline is carefully documented, and 
provide backing for initiating appropriate treatment, and vocational and community supports. 
When evaluating the effects of the disorder and its treatment 
Serial neuropsychological assessments provide an invaluable tool for guiding and 
evaluating treatment effects, detecting clinically meaningful changes in cognition or 
behaviour associated with medication changes or following neurosurgery in adult and 
paediatric populations. For instance, in drug naïve patients with new onset epilepsy a baseline 
neuropsychological assessment forms the platform from which to reliably detect drug effects 
on repeat assessments.23 The assessment may also be valuable in detecting non-compliance 
with treatment regimes, revealing the presence of a deficit in memory, language or executive 
function that prevents a patient from being able to follow the schedule of medication dosing 
prescribed by the physician. In this case the findings indicate that non-compliance is not a 
matter of will or motivation but rather an inherent limitation in the person’s ability to 
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comprehend or follow instructions. Accelerated forgetting may also be evident in some 
patients, who perform well on standard neuropsychological assessment, but display rapid loss 
of newly learned information over the following days or weeks. Accelerated forgetting is a 
common, persistent memory complaint after transient epileptic amnesia (TEA), and may be 
best detected by repeat assessments targeting anterograde memory function over a short time 
interval.24 
When not to refer 
Other than in certain circumstances, people are not routinely referred for a repeat 
neuropsychological assessment within six to nine months of a previous assessment. Practice 
effects can obscure deterioration on tests that would otherwise be sensitive to pathological 
decline. This is particularly true for measures of attention, memory, speed of information 
processing and higher-level executive functions.25 Exceptions to this rule of thumb include 
when someone has experienced an episode of status epilepticus or other major event or illness 
that may have resulted in a significant stepwise deterioration of function. 
Neuropsychological assessment may also be impractical and add limited information in the 
setting of an acute insult or illness that is expected to recover over a short period of time. This 
includes assessment of patients during the post-ictal phase, where diffuse cerebral dysfunction 
produced by a seizure provides limited diagnostic information. Rather, the level of 
impairment and evolution of recovery in the acute setting may be evaluated more efficiently 
by brief bedside examination of basic cognitive functions.26 This type of assessment can also 
be useful when evaluating a patient’s ability to provide informed consent in the acute setting. 
WHAT CAN BE EXPECTED FROM AN ASSESSMENT? 
Reliable and valid test results 
Since this report focuses on the importance of neuropsychological assessment for 
addressing core clinical questions in people with epilepsy, we are not going to recommend 
specific cognitive tests or neuropsychological assessment batteries. Test batteries have been 
previously recommended,27,28 but are subject to regional variations and need to take cultural 
and linguistic factors into account.29 Here, we recommend that at a minimum a 
neuropsychological assessment cover a core set of cognitive domains that are universal (Table 
1). These domains should be tested using standardised measures with robust psychometric 
properties, and culturally specific, up-to-date norms. In some countries, standard tests of 
effort are also routinely used to ensure reliability of assessment results. For serial 
assessments, reliable change indices or standardised regression-based measures should be 
used to assess change over time.31 Whilst a core battery of tests can be valuable, an 
increasingly common approach is to use a flexible battery with additional tests tailored to the 
clinical referral question and the individual needs of the patient. This allows careful 
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assessment of the functioning of specific domains, based on hypotheses generated from 
clinical interview, observation of the patient, and review of medical records. Such flexibility 
is especially important for the approach to assessment with children, as tests need to be age-
sensitive and appropriate for the child’s developmental level. 
(Insert Table 1 about here) 
It should be noted that most neuropsychological tests and their normative databases have 
been developed in upper-income settings. While there is a clear need to adapt them to other 
low- and middle-income settings, this needs to proceed carefully and deliberately. Test item 
content may be highly culture-bound. Some people in these settings may have limited 
experience in school and thus may be less familiar with the goals and processes of 
assessment. Whenever possible, validations studies should be carried out in local populations 
and local norms developed. Also relevant is the emerging global issue of an aging world 
population and the need for validations studies in elderly patients with epilepsy. Given the 
increased risk of both epilepsy and neurocognitive disorders with advancing age, we 
recommend routine neuropsychological assessment in elderly patients, particularly in those 
with new onset epilepsy.32 
Psychological assessment 
It is important not to forget the ‘psychological’ in a neuropsychological assessment. This 
involves evaluating the impact that epilepsy is having on the individual and the family, 
including patient and family beliefs about the disorder, its perceived stigma, and available 
coping resources. Typically, this assessment will cover a range of psychosocial domains, 
including the patient’s mood and psychological functioning, as well as physical, 
educational/vocational, family and social functioning (Table 1). Quantitative metrics derived 
from measures of health related quality of life, such as the Minimum Clinically Important 
Difference (MCID), assess the impact of epilepsy across these domains, including the extent 
of any change following treatment.33 Dimensional measures of personality and mood, and 
behavioural symptom checklists can provide additional information about psychopathology 
and behavioural co-morbidities, including potential risk and protective factors relevant to 
individual patients. Given the high co-morbidity of depression and anxiety in epilepsy, risk for 
depression and its complications (such as suicide) should be screened for routinely.34,35 Such 
information is vital to disentangling the neurological, psychological and social factors 
contributing to a patient’s clinical presentation, and in some instances, may lead to a 
recommendation for formal psychiatric evaluation as an outcome of the neuropsychological 
assessment. 
Qualitative assessment 
Qualitative approaches, such as clinical interview and careful observation of a patient’s 
presentation and behaviour, form an integral part of the neuropsychological assessment, 
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informing case formulation and clinical recommendations. At the very least, a 
neuropsychological assessment should include a detailed history of cognitive and behavioural 
complaints, and an account of their subjective impact on everyday function. Careful 
characterisation and delineation of ictally-related as compared to inter-ictal changes in 
cognition and behaviour are imperative for providing an accurate neuropsychological 
assessment. Likewise, a clear history of the timing of cognitive or behavioural changes 
relative to seizure frequency and specific treatment interventions can be fundamental to 
guiding clinical decision-making and future treatments. For patients presenting acutely, or 
otherwise not amenable to psychometric testing, a qualitative assessment or bedside 
neurobehavioural examination may provide the only viable means of directly evaluating the 
patient’s current cognitive and psychological status. Observer-based measures or detailed 
clinical interview with carers and/or family members provide other important perspectives. In 
the latter case, it is worth keeping in mind that family aggregation of cognitive or psychiatric 
issues may be pertinent to the attribution of difficulties observed in the patient. 
Case formulation 
A neuropsychological assessment should provide the referring clinician with an objective 
profile of cognitive function across multiple cognitive domains. This should include a clear 
description of the cognitive strengths and weaknesses of the patient relative to estimated 
premorbid levels of functioning. The case formulation should also address the patient’s 
emotional and psychosocial profile, and identify factors likely contributing to any deficits 
identified on qualitative and quantitative examination. From mood to medication, these 
factors are heterogeneous and can be fixed or fluctuating, irreversible or remediable (Figure 
1), informing clinical decisions relating to diagnosis, prognosis and treatment. 
Feedback and clinical recommendations 
A neuropsychological assessment should also provide clear advice about the clinical 
implications of the assessment results, including the need for any future reviews or other 
investigations and when these might best occur. Providing feedback to patients and families 
forms a key part of the assessment process and can have direct therapeutic benefits, enhancing 
cognitive and emotional wellbeing.36 Feedback typically includes psychoeducation about the 
nature of perceived cognitive difficulties, their basis and relationship to the epilepsy, as well 
as any other psychological factors that are relevant. Specific clinical recommendations should 
be made about what (if anything) can be done to improve a patient’s cognitive or 
psychosocial functioning to alleviate the distress of any difficulties identified. Evidence for 
neuroplasticity in the paediatric and adult brain underpins an expanding literature on 
neurorehabilitation and the use of cognitive retraining to assist patients with memory or other 
cognitive deficits after brain injury.37 Whilst epilepsy research in this area is still in its 
infancy, a number of studies have demonstrated effective cognitive rehabilitation strategies 
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for impairments of attention and memory in patients with epilepsy.38-40 These strategies 
include cognitive retraining paradigms and compensatory strategies to circumvent difficulties 
in daily life, which can be recommended alongside of educational, vocational or community 
supports to assist patient and family psychosocial functioning.41 Where relevant, 
psychological treatments such as cognitive behaviour therapy or anxiety management, can 
also be recommended to assist patient and family adjustment to epilepsy, complementing 
medical therapies.42-44 
CONCLUSIONS 
Neuropsychological assessment is a noninvasive and minimally resource intensive 
investigation in people with epilepsy. There has been a long and productive relationship 
between neuropsychology and epilepsy, perhaps more so than in any other condition, and 
while this relationship has grown from the specific area of epilepsy surgery, it has now 
extended far outside this area. Given its breadth and depth of scope, neuropsychological 
assessment remains a pivotal investigation in the routine care of people with epilepsy that 
provides unique information about brain functioning, even in our current age of 
neuroimaging. Its strength lies in its consideration of the whole person embedded within a 
broader social and cultural context, bringing together complex, interacting processes of mind, 
brain and behaviour that directly inform diagnosis, prognosis and treatment. Considered in 
this light, the current challenges associated with treating epilepsy and its often broad 
psychosocial effects call for increased use of neuropsychological services across international 
epilepsy settings to complement the range of other diagnostic and treatment modalities 
required to improve the care of people with epilepsy in the 21st century. 
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Table 1. Core cognitive and psychological domains  
Cognitive Domains 
General level of intellect Estimated premorbid intellect 
Current intellectual function 
Memory Learning, short- and long-term recall, recognition 
Autobiographic, prospective and semantic memory 
Different types of verbal and nonverbal material 
Language Receptive and expressive oral and written functions 
Numeracy Mental arithmetic, numerical calculations 
Spatial functions Visuoperceptual and visuoconstructional abilities 
Executive functions Attention, working memory, processing speed, idea 
generation (fluency), planning, cognitive flexibility (switching), 
response inhibition, social cognition* 
Somatosensory and motor functions Sensory-motor perception and response, speed, praxis 
Psychological Domains 
Personality Dimensional personality traits 
Mood Depression, anxiety 
Behaviour Illness beliefs, coping strategies 
Quality of life and daily psychosocial functioning 
Screening of other psychiatric disorders and behavioural co-
morbidities 
*While not routinely tested, social cognition is being increasingly recognised as relevant to the assessment of 





Factors influencing performance on neuropsychological tests in epilepsy (from Baxendale & 
Thompson, 2010). 
